Stereotaxis, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated July 7, 2026, reports the completion of Stereotaxis, Inc.'s acquisition of 100% of the share capital and voting power of Robocath, a French société par actions simplifiée. The transaction was executed pursuant to a Share Sale Agreement dated April 14, 2026.
Key Financial Metrics and Transaction Details
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, or debt levels for the reporting period. The primary financial data relates to the acquisition consideration:
- Total Consideration: Approximately $20 million in cash and Common Stock.
- Equity Issued at Closing: 1,469,485 shares of Common Stock issued to Robocath securityholders.
- Warrants Issued: "Pre-funded" warrants to purchase 4,575,143 shares of Common Stock issued to a securityholder electing this option in lieu of stock.
- Advisor Compensation: 225,000 shares of Common Stock issued to Robocath's financial advisor as a success fee.
- Contingent Consideration: Potential additional issuance of shares or warrants up to $25.0 million in aggregate if earnout performance targets are met.
Material Changes
The material change reported is the expansion of Stereotaxis's operations through the acquisition of Robocath. This transaction results in a significant increase in outstanding shares and warrants, subject to a cap of 19.9% of pre-transaction outstanding shares without further stockholder approval. The company is required to file a resale registration statement for the stock consideration.
Outlook, Risks, and Contingencies
Management anticipates benefits from the acquisition, including strategic implications and potential regulatory and commercial milestones. However, the filing highlights several risks and contingencies:
- Integration Risks: Uncertainty regarding the successful integration of Robocath's operations and the retention of key personnel.
- Performance Risks: Potential failure to achieve earnout targets or realize anticipated benefits within expected timeframes.
- Revenue Recognition: No assurance that revenue related to purchase orders will be recognized due to external contingencies that may lead to delays or cancellations.
- Forward-Looking Statements: The company disclaims any obligation to update forward-looking statements regarding the transaction's impact.
Key Facts for Investor Verification
- Verify the exact cash portion of the $20 million total consideration versus the equity portion.
- Confirm the specific earnout performance targets and the timeline for the $25.0 million contingent consideration.
- Monitor the filing of the resale registration statement for the upfront stock consideration.
- Assess the dilution impact of the 1,469,485 shares and 4,575,143 warrants issued at closing.
- Review future filings for updates on the integration progress and any regulatory milestones achieved by Robocath.